Smith & Nephew (SNNUF) Gains from Investment Securities (2009 - 2024)

Smith & Nephew (SNNUF) reported Gains from Investment Securities of -$71.0 million for Q4 2024, down 12.7% on a YoY basis from -$81.3 million in Q1 2024, and down 12.7% quarter-over-quarter from -$63.0 million in Q4 2023.

Smith & Nephew (SNNUF) Gains from Investment Securities (2009 - 2024) Analysis & Trends

Smith & Nephew has reported Gains from Investment Securities for 16 years, with the latest figure at -$71.0 million in Q4 2024.

  • For the quarter ending Q4 2024, Gains from Investment Securities fell 12.7% year-over-year to -$71.0 million; the trailing twelve-month figure through Dec 2024 stood at -$179.0 million (down 28.78% YoY), and the FY2025 full-year result was $23.0 million, up 4.55% from the prior year.
  • Gains from Investment Securities for Q4 2024 stood at -$71.0 million, down from -$63.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $13.0 million in Q4 2022, with the low at -$71.0 million in Q4 2024.
  • Historically, Gains from Investment Securities has averaged -$42.0 million across 5 years, with a median of -$58.0 million in 2021.
  • Annual changes were most pronounced in 2022 — Gains from Investment Securities surged 122.41% — and 2023, when it sank 584.62%.
  • Smith & Nephew's Gains from Investment Securities stood at -$31.0 million in 2020, then sank by 87.1% to -$58.0 million in 2021, then surged by 122.41% to $13.0 million in 2022, then slumped by 584.62% to -$63.0 million in 2023, then slipped by 12.7% to -$71.0 million in 2024.
  • The last three Gains from Investment Securities figures came in at -$71.0 million (Q4 2024), -$63.0 million (Q4 2023), and $13.0 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Smith & Nephew - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -71.00 Mn
Dec 31, 2024 -71.00 Mn
Dec 31, 2023 -63.00 Mn
Dec 31, 2023 -63.00 Mn
Dec 31, 2022 13.00 Mn
Dec 31, 2022 13.00 Mn
Dec 31, 2021 -58.00 Mn
Dec 31, 2021 -58.00 Mn
Dec 31, 2020 -31.00 Mn
Dec 31, 2020 -31.00 Mn
Dec 31, 2019 -150.00 Mn
Dec 31, 2019 -150.00 Mn
Dec 31, 2018 -125.00 Mn
Dec 31, 2018 -125.00 Mn
Dec 31, 2017 -135.00 Mn
Dec 31, 2017 -135.00 Mn
Dec 31, 2016 -141.00 Mn
Dec 31, 2016 -141.00 Mn
Dec 31, 2015 -137.00 Mn
Dec 31, 2015 -137.00 Mn